tirzepatide for nash Tirzepatide: A Promising Drug Type 2 Diabetes and Beyond Nearly 62% achieve MASH resolution
Description
On March 20, 2026, Chinas patent on semaglutide (the active ingredient in Ozempic and Wegovy) expiresyears ahead of patent expirations in the U.
The Delhi High Court's judgment reflects a growing judicial inclination to apply a sharper urgency filter in commercial IP appeals, particularly where alternative remedies are available.
Learn about Meow-1, the new GLP-1 drug for cat obesity, and how long-term implants could replace daily injections.
GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity
Auxilia na melhora da composio corporal
CDSCO had previously sought more data before approving Icodec
